$10 Billion Deal, page-13305

It’s hard to know just how closely the ASX monitors the “continuous disclosure rules”, for example supposing Biotron did know ALL the data from the Covid trial but delayed disclosure for as long as possible to suit their own purpose, however, they did disclose results so no alarm bells started to ring for the ASX so it was not an issue. Now supposing that not ALL the data was released, who would know?, not the ASX, they are not following the science of Biotron. So it is possible that the blood viral levels were known, and they were a failure as well, this would mean that the Covid human trials were undisputedly a failure. But if you only release the data for the nasal swabs and nothing more, there remains that doubt that maybe the trial wasn’t a failure at all, maybe the blood viral loads were way down but we don’t know because that part of the data was not released. So hope remains.